摘要
目的:研究靛玉红抗血管生成作用及相关机制。方法:以tgfli1:eGFP(+/-)斑马鱼为模型,实验分空白对照组、二甲基亚砜组、靛玉红组(15μM、30μM、90μM)、阳性SU5416对照组,在12hpf时加药,于48hpf时在荧光显微镜下观察其体节间血管生成情况,并进行定量分析。运用整体原位杂交的方法和RT-PCR技术检测flk1基因的表达情况。结果:与空白对照组相比,靛玉红各浓度组体节间血管长度有显著性差异(P<0.01),并呈剂量依赖性抑制;与空白对照组相比,靛玉红对斑马鱼胚胎flk1mRNA表达有明显抑制作用,并随浓度的增高而增加。结论:靛玉红(15μM~90μM)具有抑制斑马鱼胚胎体节间血管生成的作用,其机制可能是通过阻断VEGF/VEGFR2信号通路的某个环节来发挥作用。
Objective: To investigate the antiangiogenic activity and related mechanism of indirubin in zebrafish embryos. Methods: The antiangio- genic activity was tested with in vivo transgenic zebrafish embryos, and its mechanism was clarified in zebra_fish by gene expression analysis of the vascular endothelial growth factor receptor2 (VEGFR2) . The expression of VEGFR2 was detected by RT-PCR assay and whole mount in situ hybridization (WISH). Results: The treatment of zebrafish embryos with indirubin manifested potent anti-angiogenic activity against in- tersegmental vessels formation. WISH and semi-quantitative RT-PCR analysis showed that indirubin dose-dependently reduced the mRNA ex- pression of vascular endothelial growth factor (VEGF) receptor2 (VEGFR2). Conclusions: The study suggested that indirubin could inhibit angiogenesis of intersegmental vessels of the zebrafish embryos through inhibition of the phosphorylation of certain protein in the VEGF/VEG- FR2 pathway, which results in down-regulation of VEGFR2 mRNA expression.
出处
《中药药理与临床》
CAS
CSCD
北大核心
2012年第4期32-34,共3页
Pharmacology and Clinics of Chinese Materia Medica
基金
广州市白云区科技计划
课题号:2010-KZ-37
关键词
靛玉红
血管生成
血管内皮生长因子受体
斑马鱼
indirubin (靛玉红)
angiogenesis
vascular endothelial growth factor receptor
zebrafish